Coronavirus Notebook: Remdesivir Enters Study, Outspoken Physician's Death Sparks Anger
Condolences And Outrage Over Death
Gilead’s remdesivir is used for mild and moderate patients after an astonishing clinical approval in China, while the nation mourns the loss of an outspoken 34-year old physician died on Feb.6 of the virus.
You may also be interested in...
In a shocking and revealing account, a primary investigator of the front-runner antiviral drug for the coronavirus in China expresses concerns over finding enough patients for the study Wuhan, the outbreak's epicenter.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.